Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

DeepMind is Google's AI research hub focused on building artificial general intelligence. DeepMind has been applied to real-world problems in healthcare, science, and engineering. DeepMind has a ...

DeepMind’s NHS research contracts also transferring to Google Health suggests the tech giants wants zero separation between core AI health research and the means of application, using its own ...

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...

Google's DeepMind launches AlphaGenome, an artificial intelligence model that predicts gene expression from DNA sequence.

Hassabis co-founded DeepMind in 2010 with Shane Legg and Mustafa Suleyman, and Google acquired the company for $500 million in 2014. The lab would go on to make headlines numerous times in the ...

Google Health will fold in the healthcare arm from its British artificial intelligence lab DeepMind. DeepMind's healthcare unit produced Streams, an app to improve patient healthcare. But that app ...

DeepMind, a subsidiary of Google, has announced DeepMind Health, ... The app’s proven successful in early trials: during a test at St Mary’s Hospital in London, ...

Google’s decision to bring DeepMind Health, the medical unit of the AI-powered company it acquired four years ago, closer to the mothership may leave 1.6 million NHS patients with “zero ...